Wet lab work, including the field of high pace cancer research, suffers from reports of alarmingly high heterogeneity of results during confirmatory experiments. Science policies of leading industry nations have established guidelines to support funding givers, stakeholder of the publication business and scientists and their academic institutions to combat this issue in prospective research campaigns.

MES has established a quality control system suitable for academic preclinical lab environment, where limited amount of funding and rapid turnover of examinations is common. In a continuation of this, we have set up digital lab note reporting, allowing a rapid and transparent stakeholder engagement and scientific project administration. Moreover, we conduct research on identifying sources of heterogeneity of cancer research results focusing on the in vitro research sector. We aim to ensuring best possible means of internal and external validity of our work.